Mark Deadwyler

Mark Deadwyler serves as the Chief Financial Officer at Elemental Enzymes since September 2023. Previously, Mark held the position of Executive Vice President and Chief Financial Officer at Reconext from January 2021 to May 2023, where responsibilities included overseeing aftermarket services and reverse supply chain solutions for electronic devices. Prior to that, Mark was the Senior Vice President and Chief Financial Officer for Global Operations at Teva Pharmaceuticals, managing a significant finance organization and a $1.3 billion sales portfolio. Mark's extensive career at Monsanto Company spanned over 25 years, during which several key roles included Vice President of Finance for Global Supply Chain and Vice President of Finance and Alliances for Global Research and Development. Mark's educational background includes an MBA in Finance and a Bachelor's degree in Business Administration with a focus on Marketing.